English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The microbiological studies of ”Propolis-Derma” medicated products (“Propolis-PNH”, “Propolis-PSC” and “Propolis-PCD”) with the antifungal, antimicrobial and keratolytic activity developed for the treatment of dermatomycoses, pityriasis versicolor, аs well as diseases caused by yeast-like fungi of Candida genus have been carried out. The results of the experiments conducted indicate that the test samples studied show marked antagonistic properties against gram-positive bacteria (S. aureus, В. subtilis), the selective antibacterial ability in relation to Е. Соlі and the expressed antifungal action against the strains of Candida albicans genus. It has been determined that the pharmaceutical compositions proposed do not reveal the adverse action and comply with the requirements of the State Pharmacopeia of Ukraine. They can be used to treat mycoses in conditions of high resistance of fungi to traditional antifungal drugs.

Creation of pharmaceutical compositions with the antifungal, antimicrobial and keratolytic activity